Award recordCONTRACT

EISAI INC.

PIID 36C26019N0107· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $53,048 net obligations· UEI M3K9M1DWKFR5· NJ

Description

LENVIMA 8MG AND 24MG BPA

First action · last action
2018-10-09 · 2019-04-30
Transactions
2
First transaction's obligation
$264,950
Base + all options value (sum of deltas)
$53,048
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36E79718A0004
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$264,950$0Base award · 2018-10-09 · this action $264,950 · running total $264,950Modification P00001 · 2019-04-30 · this action -$211,902 · running total $53,048
  • Base2018-10-09+$264,950= $264,950
  • Mod P000012019-04-30-$211,902= $53,048
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-09+$264,950$264,950LENVIMA 8MG AND 24MG BPA
Mod P00001· FUNDING ONLY ACTION2019-04-30−$211,902$53,048LENVIMA 8MG AND 24MG BPA

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M3K9M1DWKFR5)

AwardOffice · PSC / listingNet obligationsFY
36F79724D0132NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26119F0198261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019
36C26019N0277260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019
36C25919F0147NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$10,871FY2019
36C25919F0133NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$12,703FY2019
36C26319N0509NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS$9,950FY2019

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019N0107_3600_36E79718A0004_3600 · retrieved 2026-09-26.